FIELD: chemical industry. SUBSTANCE: present invention describes indole derivatives of general formula I
wherein E is straight or branched C1-C4-alkylene chain: R is group of formula: -CH2-CHR1-NR2R3 wherein R1 is hydrogen; R2 and R3 are identical and are C1-C6-alkyl. The claimed process comprises reacting 4-amino-1,2,4-triazole with nitrobenzene derivative containing readily replaceable group, deaminating the thus obtained aminotriazolium salt by treatment with nitrogenous acid followed by neutralization, reducing the thus obtained triazolinyl- nitrobenzene derivative by transfer hydrogenation, treating the thus obtained triazolyl-aniline derivative with nitrogenous acid and then with alkali metal sulfate followed by acidification, and the thus obtained triazolyl-hydrazine derivative is then reacted in reaction medium with suitable carbonyl compound of formula:
wherein Alk is methyl. The desired compound with yield of 96% is obtained without isolation of intermediate compounds. EFFECT: more efficient preparation process. 10 cl, 2 ex
Title |
Year |
Author |
Number |
SUBSTITUTED MORPHOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON SAID, METHOD OF DECREASE OF TACHIKININ LEVEL IN TREATMENT OR PROPHYLAXIS OF PHYSIOLOGICAL STATES ASSOCIATED WITH TACHIKININ EXCESS |
1994 |
- Rejmond Bejker
- Timoti Kharrison
- Angus Mjurrej Makled
- Ehndrju Pehjt Ouvens
- Ehjlin Mehri S'Juard
- Kristofer Dzhon Svejn
- Martin Richard Till
|
RU2131426C1 |
N,N-DIMETHYL-2-[5-(1,2,4-TRIAZOLE-1-YL-METHYL)-1H-INDOLE-3-YL]-ETHYLAMINE SULFATE SALT (2:1) AND ITS PHARMACEUTICALLY ACCEPTABLE HYDRATES, METHODS OF ITS PREPARING, A PHARMACEUTICAL COMPOSITION ON ITS BASE, A METHOD OF ITS PREPARING AND A DRUG |
1993 |
- Rajmond Bejker
- Viktor Gilio Matassa
- Karol' Oliv
- Kendal Dzhordzh Pitt
- Dehvid Ehdvard Stori
- Lesli Dzhozef Strit
- Aleksandr Richard Giblin
|
RU2130022C1 |
OESTROGEN RECEPTOR MODULATORS |
2005 |
- Grinli Mark L.
- Mehn Dunfan
- Sperbek Donald M.
- Uildondzher Kennet Dzh.
|
RU2394820C2 |
DERIVATIVES OF ARYLSULPHONYLSTILBENE FOR TREATMENT OF INSOMNIA AND ASSOCIATED WITH IT DISORDERS |
2005 |
- Dzhilligan Mira
- Khamfriz Aleksandr Charl'Z
- Khant Piter Alan
- Ladduvakhetti Tamara
- Makleod Angus Mjurrej
- Merchant Kevin Dzhon
|
RU2382766C2 |
APPLICATION OF ATASANAVIR FOR IMPROVEMENT OF PHARMAKINETICS OF UGT1A1-METABOLISED MEDICATIONS |
2005 |
|
RU2403066C2 |
TETRAHYDROPYRANYL-CYCLOPENTYL-TETRAHYDROPYRIDOPYRIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY |
2003 |
- Dziao Richard
- Morriehllo Gregori
- Jang Likhu
- Mojes Kristofer
|
RU2285004C2 |
PYRIDYL-PIPERIDINE ANTAGONISTS OF OREXIN RECEPTORS |
2008 |
- Breslin Majkl Dzh.
- Koulman Pol Dzh.
- Koks Kristofer D.
- Shrajer Dzhon D.
|
RU2470021C2 |
PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3-YL]PHENYL}-2H-INDAZOLE-7-CARBOXAMIDE |
2009 |
- Fouli Dzhennifer R.
- Uilson Robert Darrin
|
RU2495035C2 |
METHOD OF PREPARING 5-(1,2,4-TRIAZOL-1-YL)TRIPTAMINE COMPOUNDS, AND 2-[5- (1,2,4-TRIAZOL-1-YL)-1H-INDOL-3-YL]ETHANOL |
1995 |
- Cheng J.Chen
- Robert D.Larsen
- Tomas R.Verkhoehven
|
RU2138496C1 |
AKT ACTIVITY INHIBITORS |
2006 |
- Armstrong Donna Dzh.
- Khu Ehssa Kh.
- Kelli Majkl Dzh. Iii
- Lejton Mark Eh.
- Li Ivehj
- Ljan Tszjun'
- Rodzinak Kevin Dzh.
- Rossi Majkl A.
- Sanderson Filip Eh.
- Van Tszjabin
|
RU2421454C2 |